AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29846091
Drug: Melatonin (MEL)
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (MEL) 10 mg
Trial: 28059034
Drug: Midazolam 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 2.5 mg and Haloperidol 2.5 mg (IM) plus Morphine 0.05 mg/kg (IV)
Trial: 28059034
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water 5 cc (IM) plus Morphine 0.05 mg/kg (IV)
Trial: 20660712
Drug: Potential markers
RxNorm normalized name: Potentilla discolor whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potential markers for cancer diagnosis, prognosis, or therapy monitoring
Trial: 18339487
Drug: IMRT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMRT with dose escalation
Trial: 10488702
Drug: Blood transfusion
RxNorm normalized name: Blood transfusion, auxiliary products
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood transfusion and vasoactive drugs followed by sclerotherapy
Trial: 10488702
Drug: Injection sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection sclerotherapy at diagnostic endoscopy
Trial: 9601759
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 mg/kg/day i.m. over 3 days)
Trial: 6765526
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (recombinant DNA)
Trial: 6765546
Drug: Purified porcine
RxNorm normalized name: Insulin purified porcine
DrugBank: Insulin pork (DB00071)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Purified porcine insulin (PPI)
Trial: 30589984
Drug: Cytisine capsules
RxNorm normalized name: cytisine
DrugBank: Cytisine (DB09028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytisine capsules (25-day supply)
Trial: 30589984
Drug: Varenicline tablets
RxNorm normalized name: Varenicline Tablets
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Varenicline tablets (12-week supply)
Trial: 18957828
Drug: Boron neutron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boron neutron capture therapy (BNCT) followed by X-ray treatment (XRT) of 20 to 30 Gy
Trial: 18957828
Drug: Boron neutron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boron neutron capture therapy (BNCT) (protocol 1 and 2 together)
Trial: 12381087
Drug: Continuous ATP
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ATP injection
Trial: 7616871
Drug: Gynodian Depot
RxNorm normalized name: Primoteston Depot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gynodian Depot cartridges (4 mg estradiovalerate and 200 mg prasteronenantate) given as muscular injection in 6-10 week intervals (mean 7 weeks +/- 4 days)
Trial: 2654080
Drug: naftifin hydrochloride
RxNorm normalized name: Naftifine Hydrochloride
DrugBank: Naftifine (DB00735)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: naftifin hydrochloride cream
Trial: 26486824
Drug: TAP‐144‐SR (6M)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP‐144‐SR (6M) 22.5 mg
Trial: 26486824
Drug: TAP‐144‐SR (3M)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP‐144‐SR (3M) 11.25 mg
Trial: 21574291
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy without acupuncture
Trial: 18824862
Drug: Dexibuprofen 200
RxNorm normalized name: ibuprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexibuprofen 200 mg
Trial: 18824862
Drug: Dexibuprofen 300
RxNorm normalized name: Dexibuprofen 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexibuprofen 300 mg
Trial: 16710256
Drug: Eptifibatide (Integrilin)
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide (Integrilin) administered as two boluses of 180 mg/kg followed by infusion of 2 mg/kg per min for 24 hours and 1.3 mg/kg for 48 hours
Trial: 16710256
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no GP IIb-IIIa antagonists used)
Trial: 15633811
Drug: Real intradermal
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real intradermal acupuncture on shen‐men (He‐7) and nei‐kuan (EH‐6) for 2 days
Trial: 9431347
Drug: Intensive medical
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive medical therapy and monitoring by experienced physicians and surgeons for patients with fulminant colitis, toxic megacolon, or perforation.
Trial: 7943771
Drug: Autologous +
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous + leukocyte‐depleted red blood cell transfusion (800 +/- 200 mL autologous blood and 2.2 +/- 2.0 units of SAGM red blood cells)
Trial: 31504126
Drug: 10 years
RxNorm normalized name: Neocate Junior Powder Children 1-10 years
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 years of tamoxifen treatment
Trial: 31504126
Drug: 5 years
RxNorm normalized name: Dymadon 5 Years Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 years of tamoxifen treatment
Trial: 22137077
Drug: Initial medical
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial medical therapy after publication of trial results
Trial: 8976781
Drug: 0.05% betamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% betamethasone cream applied twice daily for 4 weeks
Trial: 8976781
Drug: Neutral cream
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral cream (Vaseline) applied twice daily for 4 weeks
Trial: 1353011
Drug: L-threonine (Thr)
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-threonine (Thr)
Trial: 6396839
Drug: Cloxacillin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cloxacillin (2 g intravenously 2 hours before operation, followed by 1 g every 6 hours for 2 days and 1 g orally for 8 more days postoperatively)
Trial: 30052055
Drug: MG-NMES
RxNorm normalized name: MG 217 Psoriasis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MG-NMES
Trial: 17845270
Drug: Tamoxifen (20-140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (20-140 mg/day)
Trial: 11694609
Drug: Iron supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron supplementation (10 mg/d)
Trial: 11694609
Drug: Iron +
RxNorm normalized name: Celebrate Iron + C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron + Zinc supplementation (10 mg of each/d)
Trial: 9212763
Drug: Caffeine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (200 mg intravenously)
Trial: 1454657
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 1.6 mg daily
Trial: 1454657
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone 10 mg daily
Trial: 3306546
Drug: Twice-daily instillation
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily instillation for 1 week
Trial: 26211765
Drug: Omega-3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 PUFA in parenteral nutrition
Trial: 26211765
Drug: Control (without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (without omega-3 PUFA in parenteral nutrition)
Trial: 23205864
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone tablets 200 mg vaginally daily (Group A)
Trial: 23205864
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg progesterone intramuscular every third day (Group B)
Trial: 23205864
Drug: Intramuscular progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular progesterone (Group B)
Trial: 17080540
Drug: Xiong‐gui‐jiao‐ai‐tang (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiong‐gui‐jiao‐ai‐tang (7.5 g/day)
Trial: 11053334
Drug: Theophylline (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (4.5 mg/kg)
Trial: 10954004
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (nitrendipine or nifedipine)
Trial: 10954004
Drug: No calcium
RxNorm normalized name: DPBS 1X, NO CALCIUM, NO MAGNESIUM
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No calcium antagonists
Trial: 1553052
Drug: Heparan sulfate
RxNorm normalized name: heparan sulfate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparan sulfate (orally administered)
Trial: 27297634
Drug: Anxiolytic or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anxiolytic or hypnotic drugs
Trial: 23341518
Drug: Anthracycline-only chemotherapy
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anthracycline-only chemotherapy (doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil [CMF] or doxorubicin plus cyclophosphamide followed by CMF)
Trial: 23341518
Drug: Chemotherapy combining
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy combining doxorubicin and docetaxel (doxorubicin plus docetaxel followed by CMF or doxorubicin followed by docetaxel followed by CMF)
Trial: 23341518
Drug: Anthracycline-only chemotherapy
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anthracycline-only chemotherapy
Trial: 20595800
Drug: Pegvisomant (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegvisomant (10 to 40 mg/day for 18 months)
Trial: 8959150
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Bactec and MB‐Check systems
Trial: 1530193
Drug: Intranasal live
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal live attenuated influenza A (H3N2) virus vaccine
Trial: 4064565
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride solution (saline: 154 mmol of NaCl/l) plus ascorbic acid, 1 mg/ml (control)
Trial: 24604409
Drug: MAG gel
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAG gel in sugar cookies (40 g)
Trial: 24604409
Drug: MAG gel
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAG gel in baked products (high and low moisture)
Trial: 22801836
Drug: Peribulbar injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peribulbar injection of gadolinium and lidocaine hydrochloride, 2%, without epinephrine
Trial: 22801836
Drug: Retrobulbar injection
RxNorm normalized name: LIDOCAINE HYDROCHLORIDE 40 mg in 1 mL RETROBULBAR INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrobulbar injection of gadolinium and lidocaine hydrochloride, 2%, without epinephrine
Trial: 20131296
Drug: High-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IV cyclophosphamide (50 mg/kg daily for 4 days)
Trial: 20131296
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment (monthly IV cyclophosphamide at 750 mg/m2 for 6 months followed by quarterly IV cyclophosphamide for 2 years)
Trial: 15954952
Drug: Propofol 3
RxNorm normalized name: fospropofol 35 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3 mg/kg/h
Trial: 8750406
Drug: famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 20 mg BID
Trial: 8750406
Drug: famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 40 mg BID
Trial: 22964325
Drug: Long-pulse Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-pulse Nd:YAG 1064-nm laser treatment (8 sessions with a one-week interval)
Trial: 22964325
Drug: Long-pulse Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-pulse Nd:YAG 1064-nm laser treatment (4 sessions with a one-week interval)
Trial: 15523488
Drug: Isoflavone supplement
RxNorm normalized name: Soyrel Soy Isoflavone Supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone supplement (86 mg/day) for 2 months (study 1)
Trial: 15523488
Drug: Isoflavone supplement
RxNorm normalized name: Soyrel Soy Isoflavone Supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone supplement (86 mg/day) for 3 months (study 2)
Trial: 11772475
Drug: Routine methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine methadone treatment
Trial: 15365537
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg once daily for 10 days
Trial: 8529853
Drug: Verapamil (i.v.;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (i.v.; 10 mg)
Trial: 8529853
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (s.l.; 5-10 mg)
Trial: 6244079
Drug: Combined radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined radiation therapy and CCNU therapy (Group A: 26 cases)
Trial: 6244079
Drug: Standard radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard radiation therapy alone (Group C: 50 cases)
Trial: 23479393
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg po preoperatively followed by 200 mg po every eight hours for two days
Trial: 21216197
Drug: Dutasteride (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride (0.5 mg per day)
Trial: 17316648
Drug: Intrauterine lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrauterine lidocaine (5-mL uterine instillation of 2% lidocaine) plus buccal misoprostol (200-microg tablet)
Trial: 17316648
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline solution) plus buccal misoprostol (200-microg tablet)
Trial: 11099427
Drug: IV pentobarbital
RxNorm normalized name: Pentobarbital
DrugBank: Pentobarbital (DB00312)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV pentobarbital (mean dose 3.75 ± 1.10 mg/kg)
Trial: 11099427
Drug: IV midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV midazolam (mean dose 0.2 ± 0.03 mg/kg)
Trial: 9768320
Drug: Topical decongestion
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical decongestion
Trial: 30698279
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 adjusted to maintain serum 25(OH)D above 30 ng/mL
Trial: 28042304
Drug: Electroacupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture therapy for poststroke urinary incontinence (10 sessions)
Trial: 28042304
Drug: Sham therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham therapies (10 sessions)
Trial: 28042304
Drug: Sham therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham therapies
Trial: 18637586
Drug: Dihydroartemisinin-piperaquine (40/320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroartemisinin-piperaquine (40/320 mg, DP, group A)
Trial: 18637586
Drug: Artemether-lumefantrine (20/120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemether-lumefantrine (20/120 mg tablets, AL, group B)
Trial: 15930065
Drug: Computer-assisted cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-assisted cognitive therapy (N=15)
Trial: 15930065
Drug: Standard cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive therapy (N=15)
Trial: 1881502
Drug: Effervescent cimetidine
RxNorm normalized name: cimetidine Effervescent Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effervescent cimetidine 800 mg
Trial: 1881502
Drug: Maalox (liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maalox (liquid aluminium/magnesium hydroxide antacid)
Trial: 30862658
Drug: Empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 10 mg once daily for 24 weeks
Trial: 28098097
Drug: N. sativa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N. sativa oil (2.5 mL, once daily, per orally) along with conservative management for 12 weeks
Trial: 21797111
Drug: Thalidomide 100
RxNorm normalized name: thalidomide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 100 mg orally daily for six months plus carboplatin (AUC 7) intravenously every four weeks for up to six doses
Trial: 21797111
Drug: Carboplatin (AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (AUC 7) intravenously every four weeks for up to six doses
Trial: 19254585
Drug: fFN 0
RxNorm normalized name: (18F)FFNP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fFN 0 ng/mL
Trial: 19254585
Drug: fFN 1-49
RxNorm normalized name: 18F-FFNP
DrugBank: Fluorofuranylnorprogesterone F-18 (DB15282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fFN 1-49 ng/mL
Trial: 19254585
Drug: fFN 50-199
RxNorm normalized name: 18F-FFNP
DrugBank: Fluorofuranylnorprogesterone F-18 (DB15282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fFN 50-199 ng/mL
Trial: 19254585
Drug: fFN >
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fFN > 200 ng/mL
Trial: 8849352
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (5mg MTX/week plus 50 mg AZA/day to 7.5 mg MTX/week plus 100 mg AZA/day)
Trial: 8849352
Drug: Azathioprine (AZA)
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine (AZA) 50-150 mg/day
Trial: 8849352
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 5-15 mg/week
Trial: 8849352
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment and Azathioprine (AZA)
Trial: 2309991
Drug: Total Intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Intravenous Anaesthesia (TIVA) with propofol and alfentanil infusion
Trial: 24473367
Drug: Normal-dose CTPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal-dose CTPA (100-kVp tube energy and 100-mL CM)
Trial: 24473367
Drug: Low-dose CTPA
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CTPA (80-kVp tube energy and 75-mL CM)
Trial: 19946699
Drug: Non-WBV treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-WBV treatment (stretching of the plantar flexors at end range of dorsiflexion for five 1-min bouts)
Trial: 12669742
Drug: Alendronate 60
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate 60 mg/day
Trial: 8697058
Drug: Sibutramine doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine doses varying from 1 to 30 mg
Trial: 8697058
Drug: Sibutramine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine (various doses)
Trial: 2132640
Drug: Phosphatidylserine 25
RxNorm normalized name: Phosphatidylserine
DrugBank: Phosphatidyl serine (DB00144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine 25 mg
Trial: 2132640
Drug: Phosphatidylserine 50
RxNorm normalized name: phosphatidylserine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine 50 mg
Trial: 2132640
Drug: Phosphatidylserine 75
RxNorm normalized name: Phosphatidylserine
DrugBank: Phosphatidyl serine (DB00144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine 75 mg
Trial: 443256
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day of prednisolone
Trial: 31361535
Drug: Bevacizumab (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (15 mg/kg)
Trial: 31361535
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of pemetrexed and bevacizumab
Trial: 19808128
Drug: Microplasmin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microplasmin 0.1 mg/kg
Trial: 19808128
Drug: Microplasmin 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microplasmin 0.5 mg/kg
Trial: 19808128
Drug: Microplasmin 1
RxNorm normalized name: Microplasmin
DrugBank: Ocriplasmin (DB08888)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Microplasmin 1 mg/kg
Trial: 19808128
Drug: Microplasmin 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microplasmin 1.5 mg/kg